Article Information
History
- October 9, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Thomas Roederer1,#,*,
- Bastien Mollo2,#,
- Charline Vincent2,
- Birgit Nikolay1,
- Augusto Llosa1,
- Robin Nesbitt1,
- Jessica Vanhomwegen3,
- Thierry Rose4,
- François Anna5,6,
- Corinne Torre2,
- Emilie Fourrey2,
- Erica Simons1,
- Sophie Goyard4,
- Yves Janin7,
- Pierre Charneau5,6,
- Oxana Vratskikh3,
- Anneliese Coury2,
- Stefan Vanel2,
- Pierre Mendiharat2,
- Klaudia Porten1,
- William Hennequin2,
- Clair Mills2 and
- Francisco Luquero1
- 1Epicentre, Paris, France
- 2Médecins Sans Frontières, Paris, France
- 3Environment and Infectious Risks Research and Expertise Unit, Global Health Department, Institut Pasteur, Paris, France
- 4Unit of Lymphocyte Cell Biology, Immunology Department, Institut Pasteur, INSERM 1221, Paris, France
- 5Unit of Molecular Virology and Vaccinology, Virology Department, Institut Pasteur, Paris, France
- 6Theravectys, Paris, France
- 7Unit of Chemistry and Biocatalysis, Institut Pasteur, UMR 3523 CNRS, Paris, France
- ↵*Corresponding author: Thomas Roederer, Epicentre, 14-34 Avenue Jean Jaurès, 75019 Paris, Tel : +33 (1) 40 21 54 59, Mail: thomas.roederer{at}epicentre.msf.org
↵# These authors contributed equally